Tarsus Pharmaceuticals, Inc. TARS Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares?
- Tarsus Pharmaceuticals, Inc. (TARS) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- The total number of preferred equity shares currently held by investors that possess the right to be converted into common stock. This metric is critical for calculating fully diluted share counts and understanding potential future equity dilution for common shareholders.